Thursday, April 27, four experts including MAPS founder Rick Doblin and former US drug policy advisor Kevin Sabet debate the merits of psychedelic reform
Pairing the psychedelic substance with a serotonin blocker could greatly expand its clinical use, according to new research from the University of Pittsburgh.